TREANDA Side Effects

7022900-9 | Aplasia Pure Red Cell
on Sep 28, 2010 Male patient from UNITED STATES , weighting 242.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: aplasia pure red cell. Treanda dosage: . During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ).

7018494-4 | Idiopathic Thrombocytopenic Purpura
Patient was taking Treanda (View Usage). Patient had the following side effects: idiopathic thrombocytopenic purpura on Sep 21, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 189.6 lb, . Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), WARFARIN (View Warfarin Review and Warfarin Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ).

7013252-9 | Renal Impairment
Adverse event was reported on Sep 22, 2010 by a Male patient taking Treanda (View Usage) (Dosage: ) was diagnosed with acute leukaemia, prophylaxis, pyrexia, prophylaxis of nausea and vomiting and. Location: AUSTRALIA , weighting 83.78 lb, After Treanda was administered, patient had the following side effects: renal impairment. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), COTRIM (View Cotrim Review and Cotrim Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

7012499-5 | Decreased Appetite, Fatigue, Pancytopenia
on Sep 13, 2010 Male patient from UNITED STATES , weighting 163.1 lb, was diagnosed with chronic lymphocytic leukaemia, hypothyroidism and was treated with Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, fatigue, pancytopenia. Treanda dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).


7008237-2 | Pericardial Effusion
on Sep 17, 2010 Female patient from UNITED STATES , weighting 227.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Treanda (View Usage). Patient had the following side effects: pericardial effusion. Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ).

7006974-7 | Renal Impairment
Patient was taking Treanda (View Usage). After Treanda was administered, patient had the following side effects: renal impairment on Sep 17, 2010 from AUSTRALIA Additional patient health information: Male patient , weighting 83.78 lb, was diagnosed with acute leukaemia, prophylaxis, pyrexia, prophylaxis of nausea and vomiting and. Treanda dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), COTRIM (View Cotrim Review and Cotrim Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

7006274-5 | Chronic Myelomonocytic Leukaemia
Adverse event was reported on Sep 13, 2010 by a Male patient taking Treanda (View Usage) (Dosage: ) was diagnosed with mantle cell lymphoma and. Location: SWEDEN , 81 years of age, Patient experienced the following unwanted or unexpected effects: chronic myelomonocytic leukaemia. During the same period patient was treated with LENALIDOMIDE (View Lenalidomide Review and Lenalidomide Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), CARBOMER (View Carbomer Review and Carbomer Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), CYANOKOBOLAMIN (View Cyanokobolamin Review and Cyanokobolamin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), SULFAMETHOXAZOLE TRIMETOPRIM (View Sulfamethoxazole-trimetoprim Review and Sulfamethoxazole-trimetoprim Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

7003207-2 | Mucosal Inflammation, Neutropenia
on Sep 08, 2010 Female patient from SPAIN , weighting 136.7 lb, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type) and was treated with Treanda (View Usage). Patient had the following side effects: mucosal inflammation, neutropenia. Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), TAZOCEL (View Tazocel Review and Tazocel Label ), ENANTYUM (View Enantyum Review and Enantyum Label ). Patient was hospitalized.

7002444-0 | Bronchopneumonia, Liver Disorder, Pancytopenia
on Sep 13, 2010 Female patient from GERMANY , weighting 127.9 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Treanda (View Usage). After Treanda was administered, patient had the following side effects: bronchopneumonia, liver disorder, pancytopenia. Treanda dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ), DESFERAL (View Desferal Review and Desferal Label ), CEFTRIAXON (View Ceftriaxon Review and Ceftriaxon Label ). Patient was hospitalized.

6993615-8 | Hypertensive Crisis, Pulmonary Oedema
Patient was taking Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: hypertensive crisis, pulmonary oedema on Sep 08, 2010 from GERMANY Additional patient health information: Male patient , weighting 143.3 lb, was diagnosed with mantle cell lymphoma and. Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), TEMSIROLIMUS (View Temsirolimus Review and Temsirolimus Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), CONCOR (View Concor Review and Concor Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

6988385-3 | Multiple Myeloma
Adverse event was reported on Sep 13, 2010 by a Male patient taking Treanda (View Usage) (Dosage: ) was diagnosed with chronic lymphocytic leukaemia, hypothyroidism and. Location: UNITED STATES , weighting 163.1 lb, Patient had the following side effects: multiple myeloma (What is multiple myeloma?). During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6981455-5 | Renal Impairment
on Sep 10, 2010 Male patient from AUSTRALIA , weighting 83.78 lb, was diagnosed with acute leukaemia, prophylaxis, pyrexia, prophylaxis of nausea and vomiting and was treated with Treanda (View Usage). After Treanda was administered, patient had the following side effects: renal impairment. Treanda dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), COTRIM (View Cotrim Review and Cotrim Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6981357-4 | Candidiasis, Pneumonia
on Sep 06, 2010 Female patient from GERMANY , weighting 189.6 lb, was diagnosed with b-cell lymphoma and was treated with Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: candidiasis, pneumonia (What is pneumonia?). Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6979048-9 | Multiple Myeloma
Patient was taking Treanda (View Usage). Patient had the following side effects: multiple myeloma (What is multiple myeloma?) on Sep 09, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 163.1 lb, was diagnosed with chronic lymphocytic leukaemia, hypothyroidism and. Treanda dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6977284-9 | Septic Phlebitis
Adverse event was reported on Sep 09, 2010 by a Male patient taking Treanda (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , weighting 154.3 lb, After Treanda was administered, patient had the following side effects: septic phlebitis. Patient was hospitalized.

6977253-9 | Failure To Thrive, Hypotension
on Sep 08, 2010 Male patient from UNITED STATES , weighting 235.9 lb, was diagnosed with chronic lymphocytic leukaemia, chronic lymphocytic leukaemia recurrent and was treated with Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: failure to thrive, hypotension. Treanda dosage: . During the same period patient was treated with OFATUMUMAB (View Ofatumumab Review and Ofatumumab Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), MICARDIS (View Micardis Review and Micardis Label ). Patient was hospitalized.

6977241-2 | Decreased Appetite, Fatigue, Pancytopenia
on Sep 09, 2010 Male patient from UNITED STATES , weighting 163.1 lb, was diagnosed with chronic lymphocytic leukaemia, hypothyroidism and was treated with Treanda (View Usage). Patient had the following side effects: decreased appetite, fatigue, pancytopenia. Treanda dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6973985-7 | Neutropenia, Thrombocytopenia
Patient was taking Treanda (View Usage). After Treanda was administered, patient had the following side effects: neutropenia, thrombocytopenia on Sep 08, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 198.4 lb, was diagnosed with chronic lymphocytic leukaemia, hepatic infection, prophylaxis, hypertension, nausea (What is nausea?) and. Treanda dosage: . During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PHENERGAN (View Phenergan Review and Phenergan Label ).

6970551-4 | Hypertensive Crisis
Adverse event was reported on Aug 30, 2010 by a Male patient taking Treanda (View Usage) (Dosage: ) was diagnosed with lymphoma (What is lymphoma?) and. Location: GERMANY , weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: hypertensive crisis. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), TEMSIROLIMUS (View Temsirolimus Review and Temsirolimus Label ). Patient was hospitalized.

6945975-1 | Chills, Hyperhidrosis, Malaise, Pulmonary Hypertension, Pyrexia
on Aug 25, 2010 Male patient from UNITED STATES , weighting 233.7 lb, was diagnosed with chronic lymphocytic leukaemia recurrent and was treated with Treanda (View Usage). Patient had the following side effects: chills, hyperhidrosis, malaise, pulmonary hypertension (What is pulmonary hypertension?), pyrexia. Treanda dosage: . During the same period patient was treated with HYTRIN (View Hytrin Review and Hytrin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), COMPAZINE (View Compazine Review and Compazine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), FLOMAX (View Flomax Review and Flomax Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized and became disabled.

6945971-4 | Pancytopenia
on Aug 25, 2010 Male patient from UNITED STATES , weighting 198.4 lb, was diagnosed with chronic lymphocytic leukaemia, hepatic infection, prophylaxis, hypertension, nausea (What is nausea?) and was treated with Treanda (View Usage). After Treanda was administered, patient had the following side effects: pancytopenia. Treanda dosage: . During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PHENERGAN (View Phenergan Review and Phenergan Label ).

6945928-3 | Anorectal Discomfort, Cholestasis, Constipation, Dehydration, Liver Function Test Abnormal
Patient was taking Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: anorectal discomfort, cholestasis, constipation (What is constipation?), dehydration, liver function test abnormal on Aug 19, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 145.5 lb, . Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), METFORMIN (View Metformin Review and Metformin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), COTRIM (View Cotrim Review and Cotrim Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6943369-6 | Abscess, Rash, Staphylococcal Infection
Adverse event was reported on Aug 24, 2010 by a Male patient taking Treanda (View Usage) (Dosage: ) was diagnosed with lymphoma (What is lymphoma?) and. Location: UNITED STATES , weighting 194.0 lb, Patient had the following side effects: abscess (What is abscess?), rash (What is rash?), staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COREG (View Coreg Review and Coreg Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LASIX (View Lasix Review and Lasix Label ), LORTAB (View Lortab Review and Lortab Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6941447-9 | Bradycardia, Dyspnoea, Hypotension, Pulmonary Hypertension, Weight Increased
on Aug 24, 2010 Female patient from UNITED STATES , 73 years of age, was diagnosed with chronic lymphocytic leukaemia, prophylaxis and was treated with Treanda (View Usage). After Treanda was administered, patient had the following side effects: bradycardia, dyspnoea, hypotension, pulmonary hypertension (What is pulmonary hypertension?), weight increased. Treanda dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6941328-0 | Idiopathic Thrombocytopenic Purpura
on Jul 30, 2010 Male patient from UNITED KINGDOM , weighting 189.6 lb, was treated with Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: idiopathic thrombocytopenic purpura. Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ).

6939307-2 | Pancytopenia
Patient was taking Treanda (View Usage). Patient had the following side effects: pancytopenia on Aug 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 198.4 lb, was diagnosed with chronic lymphocytic leukaemia, hepatic infection, prophylaxis, hypertension, nausea (What is nausea?) and. Treanda dosage: . During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PHENERGAN (View Phenergan Review and Phenergan Label ).

6939251-0 | Tumour Lysis Syndrome
Adverse event was reported on Aug 20, 2010 by a Male patient taking Treanda (View Usage) (Dosage: ) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , weighting 149.9 lb, After Treanda was administered, patient had the following side effects: tumour lysis syndrome. During the same period patient was treated with OFATUMUMAB (View Ofatumumab Review and Ofatumumab Label ), LANTUS (View Lantus Review and Lantus Label ), METFORMIN (View Metformin Review and Metformin Label ), DECADRON (View Decadron Review and Decadron Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMBIEN (View Ambien Review and Ambien Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6939250-9 | Anorectal Discomfort, Cholestasis, Constipation, Dehydration, Liver Function Test Abnormal
on Aug 17, 2010 Female patient from UNITED KINGDOM , weighting 145.5 lb, was treated with Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: anorectal discomfort, cholestasis, constipation (What is constipation?), dehydration, liver function test abnormal. Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), COTRIM (View Cotrim Review and Cotrim Label ), LANTUS (View Lantus Review and Lantus Label ), HUMALOG (View Humalog Review and Humalog Label ). Patient was hospitalized.

6937470-0 | Insomnia, Rash Erythematous
on Aug 23, 2010 Male patient from UNITED STATES , weighting 188.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Treanda (View Usage). Patient had the following side effects: insomnia, rash erythematous. Treanda dosage: 144mg Q28 Days Iv Drip (6 Cycles).

6934265-9 | Cd4 Lymphocytes Decreased, Febrile Neutropenia, Platelet Count Decreased
Patient was taking Treanda (View Usage). After Treanda was administered, patient had the following side effects: cd4 lymphocytes decreased, febrile neutropenia, platelet count decreased on Aug 19, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 145.5 lb, was diagnosed with breast cancer (What is breast cancer?) and. Treanda dosage: . During the same period patient was treated with ERLOTINIB HYDROCHLORIDE (View Erlotinib Hydrochloride Review and Erlotinib Hydrochloride Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), VALTREX (View Valtrex Review and Valtrex Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), ALOXI (View Aloxi Review and Aloxi Label ). Patient was hospitalized.

6934164-2 | Pancytopenia
Adverse event was reported on Aug 17, 2010 by a Male patient taking Treanda (View Usage) (Dosage: ) was diagnosed with chronic lymphocytic leukaemia, hepatic infection, prophylaxis, hypertension, nausea (What is nausea?) and. Location: UNITED STATES , weighting 198.4 lb, Patient experienced the following unwanted or unexpected effects: pancytopenia. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PHENERGAN (View Phenergan Review and Phenergan Label ).

6933761-8 | Anaemia, Hyperglycaemia, Hyperkalaemia, Leukopenia, Thrombocytopenia, Tumour Lysis Syndrome
on Aug 18, 2010 Male patient from UNITED STATES , weighting 149.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Treanda (View Usage). Patient had the following side effects: anaemia, hyperglycaemia, hyperkalaemia, leukopenia, thrombocytopenia, tumour lysis syndrome. Treanda dosage: . During the same period patient was treated with OFATUMUMAB (View Ofatumumab Review and Ofatumumab Label ), LANTUS (View Lantus Review and Lantus Label ), METFORMIN (View Metformin Review and Metformin Label ), DECADRON (View Decadron Review and Decadron Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMBIEN (View Ambien Review and Ambien Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6928939-3 | Toxoplasmosis
on Aug 17, 2010 Female patient from UNITED STATES , weighting 167.6 lb, was diagnosed with mantle cell lymphoma and was treated with Treanda (View Usage). After Treanda was administered, patient had the following side effects: toxoplasmosis. Treanda dosage: . During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ). Patient was hospitalized.

6928917-4 | Anaemia, Hyperglycaemia, Hyperkalaemia, Leukopenia, Thrombocytopenia, Tumour Lysis Syndrome
Patient was taking Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, hyperglycaemia, hyperkalaemia, leukopenia, thrombocytopenia, tumour lysis syndrome on Aug 12, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 149.9 lb, was diagnosed with chronic lymphocytic leukaemia and. Treanda dosage: . During the same period patient was treated with OFATUMUMAB (View Ofatumumab Review and Ofatumumab Label ), LANTUS (View Lantus Review and Lantus Label ), METFORMIN (View Metformin Review and Metformin Label ), DECADRON (View Decadron Review and Decadron Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMBIEN (View Ambien Review and Ambien Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6927416-3 | Anorectal Discomfort, Cholestasis, Chronic Lymphocytic Leukaemia, Constipation, Dehydration, Hepatic Cyst, Hepatic Steatosis, Liver Function Test Abnormal, Neutropenic Sepsis
Adverse event was reported on Aug 09, 2010 by a Female patient taking Treanda (View Usage) (Dosage: ) . Location: UNITED KINGDOM , weighting 145.5 lb, Patient had the following side effects: anorectal discomfort, cholestasis, chronic lymphocytic leukaemia, constipation (What is constipation?), dehydration, hepatic cyst, hepatic steatosis, liver function test abnormal, neutropenic sepsis. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), COTRIM (View Cotrim Review and Cotrim Label ), LANTUS (View Lantus Review and Lantus Label ), HUMALOG (View Humalog Review and Humalog Label ). Patient was hospitalized.

6925866-2 | Anaphylactic Shock, Body Temperature Increased, Chills, Depressed Level Of Consciousness, Hypersensitivity, Nausea
on Aug 09, 2010 Male patient from GERMANY , weighting 156.5 lb, was treated with Treanda (View Usage). After Treanda was administered, patient had the following side effects: anaphylactic shock, body temperature increased, chills, depressed level of consciousness, hypersensitivity, nausea (What is nausea?). Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), AMLODIPINE MALEATE (View Amlodipine Maleate Review and Amlodipine Maleate Label ). Patient was hospitalized.

6924332-8 | Autoimmune Thrombocytopenia, Biopsy Bone Marrow Abnormal, Bone Marrow Failure
on Aug 11, 2010 Male patient from UNITED STATES , 60 years of age, weighting 425.0 lb, was diagnosed with b-cell small lymphocytic lymphoma, chronic lymphocytic leukaemia refractory and was treated with Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: autoimmune thrombocytopenia, biopsy bone marrow abnormal, bone marrow failure. Treanda dosage: 334 Mg Day 1,2 Q 4 Wks Iv Bolus. Patient was hospitalized.

6923446-6 | Diarrhoea, Fatigue, Pancytopenia
Patient was taking Treanda (View Usage). Patient had the following side effects: diarrhoea, fatigue, pancytopenia on Aug 09, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 198.4 lb, was diagnosed with b-cell lymphoma, insomnia, diabetes mellitus, hyperlipidaemia, atrial fibrillation (What is atrial fibrillation?), medical diet, depression (What is depression?) and. Treanda dosage: . During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ), RESTORIL (View Restoril Review and Restoril Label ), METOFORMIN (View Metoformin Review and Metoformin Label ), CRESTOR (View Crestor Review and Crestor Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), SLOW MAG (View Slow Mag Review and Slow Mag Label ), COUMADIN (View Coumadin Review and Coumadin Label ), CELEXA (View Celexa Review and Celexa Label ). Patient was hospitalized.

6922525-7 | Disease Progression
Adverse event was reported on Aug 02, 2010 by a Male patient taking Treanda (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: GERMANY , weighting 152.1 lb, After Treanda was administered, patient had the following side effects: disease progression. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6922508-7 | Skin Lesion Excision
on Aug 02, 2010 Male patient from GERMANY , weighting 180.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: skin lesion excision. Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6922507-5 | Gastritis
on Aug 02, 2010 Male patient from GERMANY , weighting 191.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Treanda (View Usage). Patient had the following side effects: gastritis. Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6922504-X | Dizziness, Nausea, Nystagmus
Patient was taking Treanda (View Usage). After Treanda was administered, patient had the following side effects: dizziness (What is dizziness?), nausea (What is nausea?), nystagmus on Aug 02, 2010 from GERMANY Additional patient health information: Male patient , weighting 218.3 lb, was diagnosed with non-hodgkin's lymphoma and. Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6922503-8 | Retroperitoneal Abscess
Adverse event was reported on Aug 02, 2010 by a Male patient taking Treanda (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: GERMANY , weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: retroperitoneal abscess. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6922492-6 | Bile Duct Obstruction, Chills, Pyrexia
on Aug 02, 2010 Male patient from GERMANY , weighting 152.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Treanda (View Usage). Patient had the following side effects: bile duct obstruction, chills, pyrexia. Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6922491-4 | Surgery
on Aug 02, 2010 Male patient from GERMANY , weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Treanda (View Usage). After Treanda was administered, patient had the following side effects: surgery (What is surgery?). Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6922485-9 | Venous Thrombosis Limb
Patient was taking Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: venous thrombosis limb on Aug 02, 2010 from GERMANY Additional patient health information: Male patient , weighting 180.8 lb, was diagnosed with non-hodgkin's lymphoma and. Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6922456-2 | Psychotic Disorder
Adverse event was reported on Aug 02, 2010 by a Female patient taking Treanda (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: GERMANY , weighting 138.9 lb, Patient had the following side effects: psychotic disorder (What is psychotic disorder?). During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ).

6922447-1 | Parotitis
on Aug 02, 2010 Female patient from GERMANY , weighting 145.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Treanda (View Usage). After Treanda was administered, patient had the following side effects: parotitis. Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

6922435-5 | Ventricular Tachycardia
on Aug 02, 2010 Male patient from GERMANY , weighting 185.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Treanda (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular tachycardia. Treanda dosage: . During the same period patient was treated with RITUXMAB (View Rituxmab Review and Rituxmab Label ). Patient was hospitalized.

6922415-X | Osteoarthritis
Patient was taking Treanda (View Usage). Patient had the following side effects: osteoarthritis (What is osteoarthritis?) on Aug 02, 2010 from GERMANY Additional patient health information: Female patient , weighting 123.5 lb, was diagnosed with non-hodgkin's lymphoma and. Treanda dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.